Salama A, Gottsche B, Mueller-Eckhardt C. Autoantibodies with drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1990;77:546.10.1111/j.1365-2141.1991.tb08624.x
Toy PT, Reid ME, Burns M. Positive direct antiglobulin test associated with hyperglobulinemia in acquired immunodeficiency syndrome (AIDS). Am J Hematol 1985;19:405.10.1002/ajh.2830190206
Rapoport AP, Rowe JM, McMican A. Life-threatening autoimmune hemolytic anemia in a patient with the acquired immune deficiency syndrome. Transfusion 1988;28:190.10.1046/j.1537-2995.1988.28288179030.x
Moallem HJ, Garratty G, Wakeham M, et al. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. J Pediatr 1987;133:279-81.10.1016/S0022-3476(98)70236-7
Salama A, Berghofer H, Mueller-Eckhardt C. Detection of cell-drug (hapten)–antibody complexes by the gel test. Transfusion 1992;32: 554-6.10.1046/j.1537-2995.1992.32692367200.x
Garratty G. Laboratory investigation of drug-induced hemolytic anemia (a seminar supplement). In: Bell CA, ed. A seminar on laboratory management of hemolysis. Washington, DC: American Association of Blood Banks, 1979.
Leger RM,Arndt PA, Ciesielski DJ, Garratty G. Falsepositive eluate reactivity due to the low-ionic wash solution used with commercial acid-elution kits. Transfusion 1998;38:565-72.10.1046/j.1537-2995.1998.38698326336.x
González CA. Successful treatment of autoimmune haemolytic anaemia with intravenous immunoglobulin in a patient with AIDS. Transplant Proc 1998;30:4151-2.10.1016/S0041-1345(98)01375-X
De Angelis V, Biasinutto C, Pradella P, Errante D. Mixed-type autoimmune hemolytic anemia in a patient with HIV infection. Vox Sang 1995;68: 191–4.10.1111/j.1423-0410.1995.tb03926.x7625078
Massabki PS, Accetturi C, Nishie IA,da Silva NP, Sato EI, Andrade LEC. Clinical implications of autoantibodies in HIV infection. AIDS 1997; 11:1845-50.10.1097/00002030-199715000-000099412703
Heddle NM, Kelton JG, Turchyn KL, Ali MAM. Hypergammaglobulinemia can be associated with a positive direct antiglobulin test, a nonreactive eluate, and no evidence of hemolysis. Transfusion 1988;28:29-33.10.1046/j.1537-2995.1988.28188127947.x3341062
Inada Y, Lange M, McKinley GF,et al. Hematologic correlates and the role of erythocyte CR1 (C3b receptor) in the development of AIDS. AIDS Res 1986;2:235.10.1089/aid.1.1986.2.2352944517
Telen MJ, Roberts KB, Barlett JA. HIV-associated autoimmune hemolytic anemia: report of a case and review of the literature. J Acquir Immune Defic Syndr 1990;3:933.
Puppo F, Torresin A, Lotti G, Balleari E, Orlando G, Indiveri F. Autoimmune hemolytic anemia and human immunodeficiency virus (HIV) infection. Ann Intern Med 1988;109:249.10.7326/0003-4819-109-3-249_23389611
Taneja-Uppal N, Rappaport S, Berger BJ, Davidson E, Rahal JJ. Human immunodeficiency virus (HIV) infection and hemolytic anemia. Ann Intern Med 1989;111:340.10.7326/0003-4819-111-4-3402757316
Schreiber ZA, Loh SH, Charles M, Abeebe LS. Autoimmune hemolytic anemia in patients with the acquired immune deficiency syndrome (AIDS). Blood 1983;62:117.
Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK. Immunological principles of adverse drug reactions.Drug Saf 2000;23:483-507.10.2165/00002018-200023060-0000211144658